Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
In Brief

Javier J. Zulueta joins Qure.ai as CMO

September 19, 2025
Vol.51 No.34
Clinical Roundup

How AI will transform mental health support for breast cancer patients, narrative review paper details

September 19, 2025
Vol.51 No.34
In Brief

Northwestern Medicine to adopt “David,” a generative AI copilot by Tempus AI Inc.

September 12, 2025
Vol.51 No.33
City of Hope deploys HopeLLM: AI platform transforms clinical workflows and patient care
Sponsored

City of Hope deploys HopeLLM: AI platform transforms clinical workflows and patient care

September 05, 2025
Vol.51 No.32
By Vijay Trisal
In Brief

CancerLinQ receives ASCO-certified RQS status

September 05, 2025
Vol.51 No.32
Clinical Roundup

Tumor-infiltrating clonal hematopoiesis findings validated by AI analysis

July 25, 2025
Vol.51 No.29
Imaging’s ride to the bottom in clinical trials—and why it matters now
Sponsored

Imaging’s ride to the bottom in clinical trials—and why it matters now

July 18, 2025
Vol.51 No.28
By Jeff Sorenson
In Brief

ACR to launch artificial intelligence economics committee

July 18, 2025
Vol.51 No.28
Clinical Roundup

AI could help pathologists match cancer patients to the right treatments faster and more efficiently, study shows

July 11, 2025
Vol.51 No.27
Drugs & Targets

Personalis, Tempus AI expand commercial partnership focused on ultra-sensitive cancer recurrence testing

July 11, 2025
Vol.51 No.27

Posts navigation

Previous1…456…16Next

Trending Stories

  • “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
    In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process
  • DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions
  • FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
    “Patients are owed another review.”
  • How City of Hope is turning microbiome science into better cancer care
  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • FDA clears fruit-flavored vapes, relaxes enforcement on black-market products with pending premarket applications
    Critics say policies clear the way for major tobacco companies to enter fruit-flavored vape market

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account